Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page
Your Search Results: 31 Clinics in the Prevea Health health system


The results below represent 27,500 women who should have had one or more cervical cancer screening tests during the previous 36 months or one cervical cancer screening test and a human papillomavirus test within the last 5 years. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
Prevea Health - Allouez
N=3459
90.84 %
View Historical Data
Prevea Health - Arcadia

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Ashwaubenon
N=2264
79.02 %
View Historical Data
Prevea Health - Chippewa Falls
N=1115
52.38 %
View Historical Data
Prevea Health - Cornell

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - East DePere
N=3744
87.42 %
View Historical Data
Prevea Health - East Mason
N=1549
83.28 %
View Historical Data
Prevea Health - Eau Claire

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Gillett
N=308
50.65 %
View Historical Data
Prevea Health - Howard
N=3228
85.10 %
View Historical Data
Prevea Health - HWC

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Kewaunee

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Lena

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Luxemburg
N=932
77.25 %
View Historical Data
Prevea Health - Marinette
N=376
48.40 %
View Historical Data
Prevea Health - Menomonie

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Mountain

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Oconto
N=740
66.89 %
View Historical Data
Prevea Health - Oconto Falls
N=458
54.80 %
View Historical Data
Prevea Health - On-Site Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Osseo

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Plymouth
N=431
72.85 %
View Historical Data
Prevea Health - Pulaski
N=850
76.12 %
View Historical Data
Prevea Health - Seymour

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Shawano Avenue

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Sheboygan
N=2829
83.14 %
View Historical Data
Prevea Health - St. Mary's
N=3446
85.69 %
View Historical Data
Prevea Health - St. Vincent

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Vernon Dr.

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Washington St.

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - West DePere
N=1771
81.48 %
View Historical Data

There is good evidence that cervical cancer screening significantly reduces the incidence of and mortality from cervical cancer. The US Preventive Services Task Force suggests most of the benefit can be obtained by beginning screening at age 21. Recommendations include screening for women ages 21 through 64 with cytology (Pap smear) at least every 3 years and for women ages 30 through 64 who want to lengthen the screening interval, screening with a combination of cytology and human papillomavirus (HPV) testing every 5 years. An individuals specific clinical considerations, risk factors, etc. determine if testing is needed at a more frequent interval. It is recommended that women speak with their health care providers to determine the appropriate interval for their particular situation. There is limited evidence to determine the benefits of continued screening in women older than 65, due to declining incidence of high-grade cervical lesions after middle age. There is fair evidence that screening women older than 65 is associated with an increased risk for potential harm (US Preventive Services Task Force). Therefore, it is also recommended that women over age 65 speak with their health care providers to determine if continued screening is appropriate for their personal medical condition.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.